Synektik Spólka Akcyjna (SNT.WA)
PLN 184.4
(-1.91%)
PLN 184.4
(-1.91%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 190.86 Million PLN | 44.79% |
| 2023 | 131.82 Million PLN | 171.69% |
| 2022 | 48.5 Million PLN | 60.27% |
| 2021 | 30.26 Million PLN | -1.28% |
| 2020 | 30.65 Million PLN | -5.94% |
| 2019 | 32.59 Million PLN | 37.55% |
| 2018 | 23.69 Million PLN | 63.02% |
| 2017 | 14.53 Million PLN | 38.66% |
| 2016 | 10.48 Million PLN | 6.54% |
| 2015 | 9.83 Million PLN | -38.81% |
| 2014 | 16.08 Million PLN | -50.19% |
| 2013 | 32.28 Million PLN | 84.65% |
| 2012 | 17.48 Million PLN | 50.46% |
| 2011 | 11.62 Million PLN | 12.23% |
| 2010 | 10.35 Million PLN | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 64.7 Million PLN | 46.16% |
| 2024 Q3 | 43.04 Million PLN | 25.31% |
| 2024 Q2 | 34.35 Million PLN | -46.91% |
| 2023 Q2 | 18.25 Million PLN | -49.65% |
| 2023 Q4 | 44.27 Million PLN | 34.12% |
| 2023 FY | 131.78 Million PLN | 171.69% |
| 2023 Q3 | 33 Million PLN | 80.85% |
| 2023 Q1 | 36.25 Million PLN | 94.91% |
| 2022 Q2 | 9.85 Million PLN | 23.79% |
| 2022 Q4 | 18.59 Million PLN | 53.91% |
| 2022 FY | 48.5 Million PLN | 60.27% |
| 2022 Q1 | 7.96 Million PLN | -19.3% |
| 2022 Q3 | 12.08 Million PLN | 22.59% |
| 2021 Q3 | 4.3 Million PLN | -43.13% |
| 2021 Q2 | 7.57 Million PLN | -11.07% |
| 2021 Q1 | 8.51 Million PLN | 3.69% |
| 2021 FY | 30.26 Million PLN | -1.28% |
| 2021 Q4 | 9.86 Million PLN | 129.1% |
| 2020 FY | 30.65 Million PLN | -5.94% |
| 2020 Q4 | 8.21 Million PLN | 42.15% |
| 2020 Q1 | 8.37 Million PLN | 21.67% |
| 2020 Q2 | 8.29 Million PLN | -0.98% |
| 2020 Q3 | 5.77 Million PLN | -30.33% |
| 2019 Q1 | 14.53 Million PLN | 214.96% |
| 2019 FY | 32.59 Million PLN | 37.55% |
| 2019 Q4 | 6.88 Million PLN | 42.97% |
| 2019 Q3 | 4.81 Million PLN | -24.34% |
| 2019 Q2 | 6.36 Million PLN | -56.22% |
| 2018 Q3 | 1.92 Million PLN | -27.22% |
| 2018 FY | 23.69 Million PLN | 63.02% |
| 2018 Q1 | 6.86 Million PLN | 157.57% |
| 2018 Q2 | 2.64 Million PLN | -61.45% |
| 2018 Q4 | 4.61 Million PLN | 139.62% |
| 2017 FY | 14.53 Million PLN | 38.66% |
| 2017 Q1 | 2.52 Million PLN | -21.52% |
| 2017 Q2 | 1.97 Million PLN | -21.69% |
| 2017 Q3 | 3.03 Million PLN | 53.51% |
| 2017 Q4 | 2.66 Million PLN | -12.14% |
| 2016 Q1 | 2.89 Million PLN | -38.1% |
| 2016 Q4 | 3.21 Million PLN | 23.2% |
| 2016 Q3 | 2.6 Million PLN | 22.13% |
| 2016 Q2 | 2.13 Million PLN | -26.15% |
| 2016 FY | 10.48 Million PLN | 6.54% |
| 2015 Q1 | -387.22 Thousand PLN | -106.55% |
| 2015 FY | 9.83 Million PLN | -38.81% |
| 2015 Q2 | 1.61 Million PLN | 516.62% |
| 2015 Q4 | 4.67 Million PLN | 608.02% |
| 2015 Q3 | 660.1 Thousand PLN | -59.08% |
| 2014 Q2 | 5.54 Million PLN | -54.69% |
| 2014 Q1 | 12.23 Million PLN | 43.69% |
| 2014 Q3 | 6.74 Million PLN | 21.63% |
| 2014 Q4 | 5.9 Million PLN | -12.39% |
| 2014 FY | 16.08 Million PLN | -50.19% |
| 2013 Q2 | 5.16 Million PLN | -36.55% |
| 2013 Q4 | 8.51 Million PLN | 33.81% |
| 2013 FY | 32.28 Million PLN | 84.65% |
| 2013 Q3 | 6.36 Million PLN | 23.16% |
| 2013 Q1 | 8.14 Million PLN | 86.04% |
| 2012 Q3 | 3.23 Million PLN | 87.48% |
| 2012 Q4 | 4.37 Million PLN | 35.28% |
| 2012 Q2 | 1.72 Million PLN | 0.0% |
| 2012 FY | 17.48 Million PLN | 50.46% |
| 2011 FY | 11.62 Million PLN | 12.23% |
| 2010 FY | 10.35 Million PLN | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Adiuvo Investments S.A. | 983 Thousand PLN | -19316.543% |
| Genomtec S.A. | -793 Thousand PLN | 24168.678% |
| Medinice S.A. | 75 Thousand PLN | -254386.16% |
| Medicalgorithmics S.A. | 35.86 Million PLN | -432.145% |